Company News: Pfizer and GSK

Share this article:

Pfizer said its full-year 2009 revenues rose 4% to $50 billion, with US revenues up 7% over 2008 to $21.7 billion and international revenues up 1% to $28.3 billion. Fourth-quarter US revenues were up 42% compared to Q4 2008, while international revenues were up 28%.

GlaxoSmithKline announced its annual results, showing 3% sales growth for 2009, with sales from “white pills in western markets” down to 30% of full-year sales from 2008's 36%. Emerging markets sales were up 20%, while sales in Japan were up 22% and consumer healthcare product sales rose 7%. The company also announced the launch of a new specialist unit to research and develop drugs for rare diseases.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Penn and Teller give take on vaccines

The Las Vegas twosome give the anti-vaccination movement their signature treatment.

GSK allegations build in Jordan and Lebanon

GlaxoSmithKline says it is investigating allegations of employee misconduct. The company said in a statement that the allegations have numbers "very similar to those reported by other companies in our sector."

Generic Celebrex is coming

Pfizer and Teva's settlement puts generic Celebrex on the market by December.